Insights from industry-leading experts
Learn key insights about specialty drug coverage, acquisition, and reimbursement from the experts
Acquisition 101
Christine Mann of the Dent Neurologic Institute and Charles Lynch of Oncology Copayment Solutions discuss the differences among product acquisitions through buy-and-bill, alternative injection or infusion centers, and specialty pharmacy.
Considerations for inventory management, minimizing waste, and administration
Bobbi Buell of OnPoint Oncology and Susie Fleecs, the administrator of a large ophthalmology practice, discuss their experiences managing inventory, product administration policies and procedures, and other logistical considerations for practices considering buy-and-bill.
Considerations for coding and reimbursement practices
Bobbi Buell of OnPoint Oncology and Susie Fleecs, the administrator of a large ophthalmology practice, discuss important components of the coding and reimbursement process, a key part of the buy-and-bill acquisition method.
To see the full series or find more expert-led content, visit our digital library.
View digital library*All references to "drugs" may also apply to biologics.
The information herein is provided for educational purposes only. Novartis cannot guarantee insurance coverage or reimbursement. Coverage and reimbursement may vary significantly by payer, plan, patient, and setting of care. It is the sole responsibility of the health care provider to select the proper codes and ensure the accuracy of all statements used in seeking coverage and reimbursement for an individual patient.
Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Novartis is not responsible for out-of-date information or errors. Novartis makes no warranty, express or implied, or assumes any legal liability or responsibility for the accuracy or completeness of any information contained on this website. All information on this website is subject to change without notice.
Understanding specialty
drug* coverage and acquisition
A guide for HCPs and offices
Insights from industry-leading experts
Learn key insights about specialty drug coverage, acquisition, and reimbursement from the experts
Acquisition 101
Christine Mann of the Dent Neurologic Institute and Charles Lynch of Oncology Copayment Solutions discuss the differences among product acquisitions through buy-and-bill, alternative injection or infusion centers, and specialty pharmacy.
Considerations for inventory management, minimizing waste, and administration
Bobbi Buell of OnPoint Oncology and Susie Fleecs, the administrator of a large ophthalmology practice, discuss their experiences managing inventory, product administration policies and procedures, and other logistical considerations for practices considering buy-and-bill.
Considerations for coding and reimbursement practices
Bobbi Buell of OnPoint Oncology and Susie Fleecs, the administrator of a large ophthalmology practice, discuss important components of the coding and reimbursement process, a key part of the buy-and-bill acquisition method.
To see the full series or find more expert-led content, visit our digital library.
View digital library*All references to "drugs" may also apply to biologics.
The information herein is provided for educational purposes only. Novartis cannot guarantee insurance coverage or reimbursement. Coverage and reimbursement may vary significantly by payer, plan, patient, and setting of care. It is the sole responsibility of the health care provider to select the proper codes and ensure the accuracy of all statements used in seeking coverage and reimbursement for an individual patient.
Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Novartis is not responsible for out-of-date information or errors. Novartis makes no warranty, express or implied, or assumes any legal liability or responsibility for the accuracy or completeness of any information contained on this website. All information on this website is subject to change without notice.